{"id":"W2109151188","doi":"10.1038/leu.2009.205","title":"Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia","year":2009,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Queen Elizabeth II Health Sciences Centre; Moncton Hospital; Hôpital Charles-Le Moyne; Alberta Cancer Foundation; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Fludarabine; Chronic lymphocytic leukemia; Medicine; Leukemia; Vidarabine; Hematology; Internal medicine; Immunology; Oncology; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005659795,0.00035125,0.0009223524,0.0003762121,0.001435236,0.001093631,0.000600595,0.005484253,0.002080156],"category_scores_gemma":[0.003612002,0.000258937,0.0005451943,0.0005329738,0.0007551563,0.0007396184,0.0002922264,0.003122483,0.0005113123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002228332,"about_ca_system_score_gemma":0.001344465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004139339,"about_ca_topic_score_gemma":0.01271383,"domain_scores_codex":[0.9995969,0.0001545951,0.00005512679,0.0000354557,0.00006237183,0.00009562354],"domain_scores_gemma":[0.9986784,0.0007475686,0.0001369526,0.00003900049,0.00008596075,0.0003121889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"observational","study_design_scores_codex":[0.01022239,0.0009846778,0.1012303,0.001079132,0.0004096078,0.4152821,0.00103455,0.001308421,0.007568013,0.006186693,0.2580723,0.1966218],"study_design_scores_gemma":[0.008266977,0.007108155,0.1520964,0.001683608,0.001218204,0.4094597,0.002649877,0.002937163,0.004724921,0.01016663,0.3994938,0.000194501],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3407187,0.06650937,0.001135067,0.4921539,0.01568495,0.0002126659,0.0004338557,0.000147676,0.0830038],"genre_scores_gemma":[0.7447952,0.02141847,0.0009406714,0.1941737,0.0256502,0.00009461807,0.0002857044,0.00004116061,0.01260027],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005484253,"threshold_uncertainty_score":0.01616776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01014922425182741,"score_gpt":0.2444044571314968,"score_spread":0.2342552328796694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}